Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Cantex Pharmaceuticals | Developing novel, well-tolerated, oral treatments of cancer and its |
Description | Developing novel, well-tolerated, oral treatments of cancer, and other serious Developing novel, well-tolerated, oral treatments of cancer and its |
Keywords | N/A |
WebSite | cantex.com |
Host IP | 23.254.161.11 |
Location | United States |
Site | Rank |
US$3,676,710
Last updated: 2023-05-14 23:59:36
cantex.com has Semrush global rank of 2,878,743. cantex.com has an estimated worth of US$ 3,676,710, based on its estimated Ads revenue. cantex.com receives approximately 424,236 unique visitors each day. Its web server is located in United States, with IP address 23.254.161.11. According to SiteAdvisor, cantex.com is safe to visit. |
Purchase/Sale Value | US$3,676,710 |
Daily Ads Revenue | US$3,394 |
Monthly Ads Revenue | US$101,817 |
Yearly Ads Revenue | US$1,221,799 |
Daily Unique Visitors | 28,283 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cantex.com. | A | 598 | IP: 23.254.161.11 |
cantex.com. | NS | 3600 | NS Record: ns35.domaincontrol.com. |
cantex.com. | NS | 3600 | NS Record: ns36.domaincontrol.com. |
cantex.com. | MX | 600 | MX Record: 0 cantex-com.mail.protection.outlook.com. |
cantex.com. | TXT | 600 | TXT Record: NETORGFT2324543.onmicrosoft.com |
cantex.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Our Company About Us Leadership Our Science Our Pipeline Therapeutic Targets Latest News Contact Us Our Company About Us Leadership Our Science Our Pipeline Therapeutic Targets Latest News Contact Us Developing novel, well-tolerated, oral treatments of cancer, and other serious illnesses Cantex is developing azeliragon, a novel antagonist of RAGE (the receptor for advanced glycation endproducts). LEARN MORE Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing novel, well tolerated, oral treatments of cancer, acute kidney injury and other serious illnesses. Cantex is led by Stephen Marcus, M.D., Neil Flanzraich and Juan Rodriguez; seasoned drug developers and pharmaceutical executives with stellar track records of developing blockbuster products and extensive transactional experience. READ MORE Azeliragon is a safe, once-daily oral medication in Phase 2/3 development that targets glioblastoma, metastatic brain tumors, breast cancer, pancreatic cancer, and |
HTTP/1.1 301 Moved Permanently Date: Fri, 24 Dec 2021 06:16:50 GMT Server: Apache X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://cantex.com/ Cache-Control: max-age=0 Expires: Fri, 24 Dec 2021 06:16:50 GMT Vary: User-Agent,Accept-Encoding Content-Type: text/html; charset=UTF-8 HTTP/2 200 last-modified: Fri, 24 Dec 2021 00:32:31 GMT cache-control: max-age=0 expires: Fri, 24 Dec 2021 06:16:51 GMT vary: User-Agent,Accept-Encoding content-type: text/html; charset=UTF-8 date: Fri, 24 Dec 2021 06:16:51 GMT server: Apache |
Domain Name: CANTEX.COM Registry Domain ID: 97714416_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-25T17:41:01Z Creation Date: 2003-05-09T18:06:00Z Registry Expiry Date: 2024-10-15T11:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS35.DOMAINCONTROL.COM Name Server: NS36.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-20T07:47:12Z <<< |